SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-007253
Filing Date
2022-01-25
Accepted
2022-01-25 11:32:52
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES IX, L.P.ATLAS VENTURE ASSOCIATES IX, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm224309d3_sc13ga.htm SC 13G/A 91073
  Complete submission text file 0001104659-22-007253.txt   92872
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Subject) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90431 | Film No.: 22551901
SIC: 2834 Pharmaceutical Preparations

Mailing Address 56 WAREHAM STREET, FLOOR 3 BOSTON MA 02118
Business Address 56 WAREHAM STREET, FLOOR 3 BOSTON MA 02118 617-588-2694
Atlas Venture Fund IX, L.P. (Filed by) CIK: 0001671219 (see all company filings)

IRS No.: 461357890 | State of Incorp.: DE | Fiscal Year End: 1012
Type: SC 13G/A